CVD Equipment Corp. Q1 2009 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2009. CVD Equipment Corporation is a smaller reporting company engaged in the design, manufacture, and sale of vacuum deposition equipment for the semiconductor, solar, and nanomaterials industries. The company operates under a percentage-of-completion revenue recognition model for custom contracts.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 |
|---|---|---|
| Revenue | $3,984,741 | $4,043,499 |
| Gross Profit | $1,027,028 | $1,216,851 |
| Gross Margin | 25.8% | 30.1% |
| Operating Income (Loss) | $(109,777) | $3,167 |
| Net Income (Loss) | $(86,348) | $19,204 |
| Cash and Equivalents | $5,561,457 | $3,201,479 |
| Working Capital | $9,677,395 | N/A |
| Total Debt (Current + Long-term) | $4,398,698 | N/A |
| Order Backlog | $13,872,000 | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 1.4% year-over-year, attributed to delayed or reduced capital expenditures by customers due to economic conditions.
- Margin Compression: Gross margin fell from 30.1% to 25.8%. Management cites increased engineering and production personnel costs to support the Application Laboratory and new product development in Nanomaterials, Energy, and Solar fields.
- Operating Loss: The company shifted from a slight operating profit of $3,167 in Q1 2008 to an operating loss of $109,777 in Q1 2009.
- Expense Reductions: Selling and shipping expenses dropped 8.2% due to lower commissions. General and administrative expenses decreased 6.0%, partially offset by increased R&D and payroll costs. A significant one-time workers' compensation shortfall of $168,000 recorded in Q1 2008 did not recur.
- Interest Expense: Interest expense increased to $64,755 from $40,888, driven by mortgages and the conversion of $500,000 of revolving credit into equipment term loans.
Guidance, Outlook, and Risks
- Liquidity: The company holds $5.56 million in cash and has $941,000 available under its $5 million revolving credit facility. Management believes current funds are sufficient for the next 12 months.
- Backlog: Order backlog decreased 9.2% to $13.87 million. Management notes that while backlog indicates expected revenue, it does not guarantee future achievement due to potential cancellations or delays.
- Legal Contingency: The company is involved in litigation with Akzo Nobel Polymer Chemicals LLC. The company seeks ~$154,000, while the customer has asserted counterclaims seeking damages of not less than $300,000 per claim. An allowance of $63,000 has been recorded against the receivable; management does not believe additional loss contingencies are required at this time.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks such as competition, financing availability, and future profitability.
Investor Verification Checklist
- Verify the sustainability of the 25.8% gross margin given the increased headcount in R&D and the Application Laboratory.
- Monitor the status of the Akzo Nobel litigation and potential impact on the $154,000 receivable and counterclaim exposure.
- Assess the utilization of the $941,000 remaining credit facility and the impact of the $500,000 term loan on future cash flow.
- Review the composition of the $13.87 million backlog to understand the timing of revenue recognition and risk of cancellation.
- Confirm the adequacy of the $78,634 allowance for doubtful accounts in light of the economic downturn and specific legal disputes.